Brief: Praxis Precision Q2 EPS USD -3.31 Vs. IBES Estimate USD -3.3
04/08/2025 13:30
Aug 04 (Reuters) - Praxis Precision Q2 operating expenses USD 76.067 million. Q2 operating income USD -76.067 million vs. IBES estimate USD -73.1 million Q2 net income USD -71.127 million vs. IBES estimate USD -70.4 million
Recent news on Praxis Precision Medicines
See all newsUS RESEARCH ROUNDUP-Arxis, Cigna, Vylor
Brief: Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Praxis Precision Medicines, Inc. reports results for the quarter ended June 30 - Earnings Summary
Praxis Precision Q2 net loss widens on higher expenses
Brief: Praxis Precision Q2 EPS USD -2.87